Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pustilnik

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Neurosurgical Review|December 3, 2024
Robot-assisted stereotactic brain biopsy: A systematic review and meta-analysisSilvio Porto Junior, Davi Amorim Meira, Beatriz Lopes Bernardo da Cunha, et al.
Clinical Neurology and Neurosurgery|October 12, 2024
Stereotactic aspiration versus conservative management for primary brainstem hemorrhage: A systematic review and meta-analysisHugo Nunes Pustilnik, Jefferson Heber Marques Fontes, Silvio Porto Junior, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Journal of Forensic Sciences|September 9, 2021
Commentary on: Dror IE, Melinek J, Arden JL, Kukucka J, Hawkins S, Carter J, et al. Cognitive bias in forensic pathology decisions. J Forensic Sci. https://doi.org/10.1111/1556-4029.14697. Epub 2021 Feb 20Peter Speth, Sarah Avedschmidt, John J Baeza, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Molecular Cancer Therapeutics|April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapyJitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Journal of Medicinal Chemistry|August 23, 2002
Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallographyStephen W Wright, Anthony A Carlo, Maynard D Carty, et al.
Journal of Medicinal Chemistry|January 17, 2014
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Neurosurgical Review|December 3, 2024
Robot-assisted stereotactic brain biopsy: A systematic review and meta-analysisSilvio Porto Junior, Davi Amorim Meira, Beatriz Lopes Bernardo da Cunha, et al.
Clinical Neurology and Neurosurgery|October 12, 2024
Stereotactic aspiration versus conservative management for primary brainstem hemorrhage: A systematic review and meta-analysisHugo Nunes Pustilnik, Jefferson Heber Marques Fontes, Silvio Porto Junior, et al.
Cancer Research|October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitorJitesh P Jani, Richard S Finn, Mary Campbell, et al.
Journal of Forensic Sciences|September 9, 2021
Commentary on: Dror IE, Melinek J, Arden JL, Kukucka J, Hawkins S, Carter J, et al. Cognitive bias in forensic pathology decisions. J Forensic Sci. https://doi.org/10.1111/1556-4029.14697. Epub 2021 Feb 20Peter Speth, Sarah Avedschmidt, John J Baeza, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Molecular Cancer Therapeutics|April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapyJitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Journal of Medicinal Chemistry|August 23, 2002
Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallographyStephen W Wright, Anthony A Carlo, Maynard D Carty, et al.
Journal of Medicinal Chemistry|January 17, 2014
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Pageof 12